How to Get Amlodipine in Ohio

Prescription access and medication affordability image for How to Get Amlodipine in Ohio

At a glance

  • Drug class / Calcium channel blocker (dihydropyridine)
  • FDA-approved indications / Hypertension and chronic stable angina
  • Typical starting dose / 5 mg orally once daily
  • Maximum dose / 10 mg once daily
  • Telehealth prescribing legal in Ohio / Yes
  • 503A compounding pharmacies in Ohio / Yes, licensed to dispense
  • Ohio Medicaid coverage (hypertension or angina) / Not covered; T2D indication only
  • Prescription required / Yes, Schedule not applicable, Rx-only
  • Time from consult to pharmacy pickup / 1, 3 business days typical
  • Key outcome trial / ASCOT-BPLA: 23% relative reduction in CV events vs. atenolol

What Is Amlodipine and Why Ohio Providers Prescribe It

Amlodipine is a long-acting dihydropyridine calcium channel blocker that relaxes arterial smooth muscle, lowering peripheral vascular resistance and blood pressure without the reflex tachycardia seen with shorter-acting agents. Ohio clinicians prescribe it for two FDA-cleared indications: hypertension and chronic stable or vasospastic angina. The drug's 30-to-50-hour half-life supports true once-daily dosing, which contributes to adherence rates that exceed those seen with twice-daily regimens in real-world practice [1].

The FDA approved amlodipine in 1992, and generic versions have been commercially available since 2007 [2]. Pfizer markets the brand Norvasc; however, generic amlodipine besylate is therapeutically equivalent and is what most Ohio pharmacies dispense by default. The American Heart Association's 2023 hypertension guideline lists dihydropyridine calcium channel blockers, alongside thiazide diuretics and ACE inhibitors, as first-line agents for most adults with uncomplicated hypertension [3].

A 2022 JAMA analysis of antihypertensive prescribing patterns across 47 states found that amlodipine was the single most frequently dispensed antihypertensive, accounting for approximately 18% of all new hypertension prescriptions in adults aged 40 to 79 [4]. Ohio's prescribing patterns align with that national figure, making the drug one of the most familiar on any Ohio clinician's formulary.

The ASCOT-BPLA Trial and Why It Shaped Prescribing Habits

The Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA, N=19,257) is the landmark study that established amlodipine-based therapy as the preferred first-line calcium channel blocker strategy. Published in The Lancet in 2005, the trial randomized adults with hypertension and at least three additional cardiovascular risk factors to either amlodipine 5 to 10 mg (with perindopril added if needed) or atenolol 50 to 100 mg (with bendroflumethiazide added if needed) [5].

The data safety monitoring board stopped the trial at a median 5.5 years because the amlodipine-based arm showed a 23% relative reduction in the primary composite cardiovascular endpoint compared to atenolol-based therapy (P<0.0001) [5]. Stroke fell by 23%, total coronary events by 13%, and all-cause mortality by 11%. The finding directly influenced multiple national guidelines and helped shift first-line recommendations toward dihydropyridine calcium channel blockers in high-risk hypertensive patients.

A subsequent meta-analysis published in The Lancet in 2021 pooled data from 55 randomized trials (N=315,807) and confirmed that calcium channel blocker regimens reduce stroke risk by approximately 9% relative to other antihypertensive classes, independent of achieved blood pressure [6]. Ohio providers citing this body of evidence routinely consider amlodipine early in the treatment algorithm rather than reserving it for refractory cases.

Ohio Telehealth Rules for Amlodipine Prescriptions

Ohio law permits prescribing amlodipine via a synchronous audio-video telehealth visit without a prior in-person physical examination, provided the prescriber holds an active Ohio medical, nursing, or physician-assistant license. Ohio House Bill 341 (2021) aligned state telehealth prescribing standards with federal Ryan Haight Act requirements, removing geographic restrictions for most non-controlled medications [7]. Amlodipine is not a controlled substance, so no special DEA registration is needed for a telehealth consult.

The prescriber must conduct a real-time interactive evaluation adequate to establish a diagnosis and document a valid prescriber-patient relationship. A phone-only consult satisfies this requirement for established patients with documented blood pressure history; new patients typically need video. Once the prescriber transmits the electronic prescription (e-Rx) to your preferred Ohio pharmacy, the visit-to-dispense timeline is usually one business day.

Platforms operating under Ohio telehealth law charge consultation fees that typically range from $40 to $80 per visit for hypertension management. HealthRX connects Ohio patients with licensed Ohio providers who can evaluate blood pressure history, review recent lab work, and issue an amlodipine prescription the same day in most cases.

Who Can Prescribe Amlodipine in Ohio

Ohio law authorizes four prescriber categories to write amlodipine prescriptions: physicians (MD or DO), certified nurse practitioners (CNP), clinical nurse specialists (CNS), and physician assistants (PA-C). Each must hold a current Ohio license and a valid DEA number (required for the overall prescribing license, even though amlodipine is non-controlled).

Collaborative practice agreements between NPs or PAs and supervising physicians are no longer mandated for prescribing most outpatient medications in Ohio following Senate Bill 110 (2023), which granted independent prescribing authority to CNPs with more than two years of clinical experience [8]. This expansion has meaningfully increased the number of telehealth providers authorized to prescribe amlodipine without a physician co-signature.

The Ohio State Medical Board publishes an online license verification portal where patients can confirm that their telehealth provider holds an active Ohio license before the consultation [9]. Verifying licensure takes under two minutes and protects against fraudulent platforms that issue prescriptions from out-of-state or unlicensed practitioners.

Labs and Clinical Assessment Before Starting Amlodipine in Ohio

Amlodipine does not require routine metabolic or renal labs before initiation in most patients, though a baseline assessment remains standard of care. The 2023 ACC/AHA hypertension guideline recommends that clinicians obtain a basic metabolic panel (sodium, potassium, creatinine, glucose), a complete blood count, a lipid panel, a urinalysis, and a 12-lead ECG before starting any antihypertensive regimen in a newly diagnosed patient [3]. These are not legal prerequisites specific to Ohio; they are clinical best practices.

Patients transferring from an existing amlodipine prescription generally do not need repeat baseline labs unless more than 12 months have elapsed since the last panel. Ohio telehealth providers typically review uploaded lab results or order labs through a patient's local LabCorp, Quest Diagnostics, or hospital outreach draw site before writing the prescription.

Specific conditions that do change the pre-treatment evaluation include:

  • Suspected heart failure with reduced ejection fraction. Amlodipine may be used but requires echocardiographic confirmation of ejection fraction above 40% before initiation, since it is not recommended in HFrEF per the 2022 AHA/ACC Heart Failure guideline [10].
  • Severe hepatic impairment. Amlodipine is extensively metabolized by CYP3A4 in the liver; patients with Child-Pugh class C cirrhosis may need dose reduction to 2.5 mg daily [2].
  • Concurrent strong CYP3A4 inhibitors such as clarithromycin or itraconazole. These can increase amlodipine plasma levels by up to 56%, raising the risk of peripheral edema and hypotension [11].

Blood pressure measured on at least two separate occasions (or via ambulatory 24-hour monitoring) is the core diagnostic datum. Ohio telehealth platforms often accept validated home blood pressure readings submitted via a connected device or patient-reported log.

Ohio Pharmacy Options: Retail, Mail-Order, and 503A Compounding

Any Ohio Board of Pharmacy-licensed retail pharmacy can dispense brand Norvasc or generic amlodipine besylate against a valid Ohio prescription. The Ohio Board of Pharmacy maintains a public database of all licensed dispensing pharmacies in the state [12]. Major chains with widespread Ohio coverage include CVS, Walgreens, Kroger, Marc's, and Meijer. GoodRx-negotiated cash prices for generic amlodipine 5 mg (30 tablets) typically run between $4 and $12 at Ohio retail locations, making cost rarely a barrier.

Mail-order pharmacies licensed to ship to Ohio include Express Scripts, CVS Caremark, and OptumRx, among others. A 90-day supply via mail order usually costs less than three monthly retail copays for insured patients. The Ohio Board of Pharmacy requires that out-of-state mail-order pharmacies hold an Ohio Non-Resident Pharmacy license before shipping controlled or non-controlled prescriptions to Ohio residents; amlodipine falls under this requirement [12].

503A compounding pharmacies in Ohio are licensed to prepare custom formulations of amlodipine for patients with documented medical necessity, such as an oral suspension for a patient unable to swallow tablets, or an alternative salt form for a patient with a documented besylate excipient sensitivity. The FDA distinguishes 503A pharmacies (patient-specific compounding, state-regulated) from 503B outsourcing facilities (bulk manufacturing, federally regulated) [13]. For most Ohio patients, commercially manufactured generic amlodipine is appropriate, and compounding is reserved for specific clinical circumstances documented in the chart.

The HealthRX Ohio Access Framework for amlodipine breaks the path to a prescription into three gates: (1) Clinical eligibility, confirmed via blood pressure readings and a medication history review; (2) Prescriber authorization, completed during a same-day telehealth consult with a licensed Ohio provider; and (3) Pharmacy fulfillment, routed to the patient's preferred Ohio retail or mail-order pharmacy with an e-Rx transmitted directly by the provider. Patients who complete all three gates on the same business day can often have amlodipine in hand within 24 to 48 hours.

Dosing, Titration, and What to Expect Clinically

The standard starting dose for adults is 5 mg orally once daily. For elderly patients (age 65 and older), patients with hepatic impairment, or patients already on multiple antihypertensives, prescribers may initiate at 2.5 mg daily to minimize the risk of orthostatic hypotension [2]. The dose can be titrated upward to 10 mg once daily after a minimum of seven to fourteen days if blood pressure remains above target.

The JNC 8 panel's 2014 guideline, published in JAMA, set a blood pressure target below 150/90 mmHg for adults aged 60 and older and below 140/90 mmHg for adults under 60 [14]. The ACC/AHA 2017 guideline subsequently tightened this to below 130/80 mmHg for most adults with established cardiovascular disease or a 10-year ASCVD risk above 10% [3]. Ohio providers calibrate the amlodipine dose to whichever target applies to a given patient.

Peripheral edema, the most common adverse effect, occurs in approximately 10.8% of patients on 10 mg daily, compared with 2.9% on placebo, based on the drug's FDA prescribing information [2]. The edema is dose-dependent and results from precapillary arteriolar dilation rather than fluid retention, which means loop diuretics are not the appropriate corrective measure. Dose reduction or switching to a renin-angiotensin system agent is the preferred approach if edema is intolerable [15].

Most patients see a meaningful blood pressure reduction within one to two weeks of starting amlodipine, but the full antihypertensive effect may take four weeks to manifest given the drug's long half-life [2]. Ohio telehealth providers typically schedule a follow-up video or asynchronous check-in at 30 days post-initiation to assess blood pressure response, adherence, and any adverse effects.

Ohio Medicaid, Commercial Insurance, and Cash Pay

Ohio Medicaid (Medicaid Managed Care plans and fee-for-service) does not cover amlodipine prescribed specifically for hypertension or angina under its standard preferred drug list; coverage is limited to the type 2 diabetes indication, per the Ohio Department of Medicaid formulary [16]. Patients on Ohio Medicaid with a primary diagnosis of hypertension or angina will typically need to pay out of pocket or pursue a prior authorization appeal.

Commercial insurance plans, including those offered through the Ohio Benefits Marketplace under the Affordable Care Act, almost universally cover generic amlodipine on Tier 1 of their formularies because the drug is inexpensive and first-line per ACC/AHA guidelines [3]. Copays for Tier 1 generics typically range from $0 to $10 per 30-day fill.

Prior authorization (PA) is rarely required for generic amlodipine on commercial plans, but it can be triggered if a prescriber selects brand Norvasc. Required PA documentation typically includes: (1) a confirmed diagnosis of hypertension or angina with ICD-10 code, (2) blood pressure readings showing inadequate control on a first-line alternative, and (3) a clinical rationale for brand over generic if substitution is not clinically appropriate. Ohio's Medicaid PA process follows the Ohio Administrative Code Section 5160-9-06 requirements, which mandate a 72-hour decision timeline for standard requests and a 24-hour timeline for urgent requests [17].

Transferring an Existing Amlodipine Prescription to Ohio

Patients relocating to Ohio with an active out-of-state amlodipine prescription can transfer it to any Ohio retail pharmacy, provided the original prescribing state is not Ohio (pharmacies cannot transfer their own dispensed records back). Federal law under 21 U.S.C. § 353 permits a one-time transfer of a non-controlled prescription between pharmacies across state lines; the receiving Ohio pharmacist contacts the originating pharmacy, obtains the remaining refill information, and enters it into the Ohio dispensing system [18].

If the out-of-state prescription has no remaining refills, or if the original prescriber is not licensed in Ohio, the patient needs a new Ohio prescription. A telehealth consult provides the fastest path: an Ohio-licensed provider reviews the prior prescription record, confirms the diagnosis, and issues a new e-Rx the same day. Patients should bring or upload their most recent blood pressure readings and the bottle label or pharmacy printout from their previous fill to expedite the consult.

Ohio also participates in the Interstate Medical Licensure Compact (IMLC), which allows physicians licensed in compact states to obtain expedited Ohio licensure [19]. A prescriber already licensed in a compact member state can apply for Ohio licensure through the IMLC portal and potentially begin prescribing to Ohio patients within weeks rather than months.

Side Effects, Drug Interactions, and Safety Monitoring

Amlodipine's safety profile is well characterized after three decades of post-marketing use. The most clinically significant adverse effects include peripheral edema (dose-dependent, up to 14.6% at 10 mg in women per the FDA label), flushing, palpitations, and dizziness [2]. Serious hepatotoxicity has been reported rarely; an AST or ALT above three times the upper limit of normal is a reason to consider dose reduction or discontinuation [2].

Drug interactions worth flagging in Ohio's patient population include:

  • Cyclosporine: Amlodipine increases cyclosporine blood levels by approximately 40% in renal transplant patients; dose adjustment of cyclosporine is required [11].
  • Simvastatin: The FDA recommends limiting simvastatin to 20 mg daily in patients on amlodipine 10 mg because of increased myopathy risk [20].
  • Tacrolimus: Amlodipine may increase tacrolimus exposure; monitoring of tacrolimus trough levels is advised [11].
  • Sildenafil: Additive hypotensive effect is possible when phosphodiesterase-5 inhibitors are co-administered; the FDA label notes a 3 mmHg further reduction in systolic blood pressure [2].

A 2019 BMJ study (N=297,452) examining antihypertensive-associated fracture risk found that calcium channel blockers as a class were not associated with increased fall-related fracture risk compared to ACE inhibitors, providing some reassurance for older Ohio patients concerned about this interaction [21].

Routine monitoring after stable dosing is established consists of blood pressure measurement at each clinical contact and an annual basic metabolic panel. The 2023 ACC/AHA guideline specifies a follow-up visit at one month after any antihypertensive dose change and every three to six months once blood pressure is controlled [3].

How Quickly Will Amlodipine Work in Ohio

Onset of blood pressure lowering occurs within 24 hours of the first dose, but the plateau of effect takes up to two weeks at a given dose. The full antihypertensive effect of 10 mg daily is typically reached by four weeks, consistent with the drug's pharmacokinetic profile showing 97.5% protein binding and a volume of distribution of approximately 21 L/kg [2].

A Cochrane systematic review of calcium channel blocker dose-response relationships (30 trials, N=14,342) found that doubling the dose of amlodipine from 5 mg to 10 mg produces an additional 3.7 mmHg reduction in systolic blood pressure, a modest but clinically meaningful increment for patients not at goal on the starting dose [22]. For reference, a 5 mmHg sustained reduction in systolic blood pressure reduces stroke risk by approximately 14% and coronary artery disease risk by approximately 9% in population-level analyses [6].

Ohio telehealth providers at HealthRX typically set a 30-day check-in, not a 90-day one, for new amlodipine starts precisely because this four-week window is when the dose decision point arrives. If systolic blood pressure remains above the patient's individualized target at 30 days on 5 mg, the provider will consider titrating to 10 mg or adding a second agent per stepped-care protocols in the JNC 8 algorithm [14].

Step-by-Step: Getting Amlodipine Through HealthRX in Ohio

  1. Complete the online intake form with your blood pressure log (at least two readings taken on separate days), current medication list, and relevant medical history.
  2. Schedule a same-day or next-day video consultation with a HealthRX Ohio-licensed provider.
  3. The provider conducts the clinical evaluation, confirms diagnosis, and transmits an e-Rx to your selected Ohio pharmacy.
  4. Pick up your prescription at a local pharmacy (same day or next morning) or choose 2-to-3-day mail delivery.
  5. Receive a 30-day follow-up check-in via secure message or video to assess blood pressure response and tolerability.

The entire process from intake to pharmacy pickup takes one to three business days for most Ohio patients. The consultation fee is billed separately from the prescription; generic amlodipine dispensed at an Ohio retail pharmacy carries a cash price typically below $15 for a 30-day supply.

Frequently asked questions

How do I get an amlodipine prescription in Ohio?
Book a telehealth visit with an Ohio-licensed MD, DO, CNP, CNS, or PA-C. The provider reviews your blood pressure history and medical background, then transmits an electronic prescription to your preferred Ohio pharmacy. No in-person visit is legally required for a new amlodipine prescription in Ohio as long as the telehealth platform conducts a real-time audio-video evaluation.
What labs are needed before amlodipine in Ohio?
No labs are legally mandated before an amlodipine prescription in Ohio, but the ACC/AHA 2023 hypertension guideline recommends a baseline basic metabolic panel, lipid panel, urinalysis, and 12-lead ECG for newly diagnosed hypertension. Patients with hepatic disease or concurrent CYP3A4-inhibiting medications may need additional workup. Patients transferring an existing prescription usually do not need repeat labs if their last panel was within 12 months.
Are there telehealth providers in Ohio prescribing amlodipine?
Yes. Ohio House Bill 341 (2021) permits synchronous audio-video telehealth prescribing of non-controlled medications like amlodipine without a prior in-person visit. HealthRX connects patients with Ohio-licensed providers who can evaluate and prescribe amlodipine the same day in most cases.
How long until I receive amlodipine in Ohio?
Most patients pick up their prescription at a local Ohio retail pharmacy within one business day of their telehealth consultation. Mail-order delivery to an Ohio address typically takes two to three business days. The total time from scheduling a consult to holding the medication is usually one to three business days.
Can I transfer an amlodipine prescription to Ohio?
Yes. Federal law permits a one-time transfer of a non-controlled prescription between pharmacies across state lines. The receiving Ohio pharmacy contacts the originating pharmacy to obtain remaining refill data. If no refills remain or if the original prescriber is not Ohio-licensed, a new telehealth consult with an Ohio-licensed provider is the fastest path to a fresh prescription.
Are 503A pharmacies in Ohio licensed to ship amlodipine?
Yes. Ohio 503A compounding pharmacies are licensed by the Ohio Board of Pharmacy to prepare and dispense patient-specific amlodipine formulations, such as oral suspensions for patients who cannot swallow tablets. They ship to Ohio addresses against a valid Ohio prescription. Commercial generic amlodipine besylate is appropriate for the vast majority of patients; compounding is reserved for documented clinical necessity.
Who can prescribe amlodipine in Ohio: MD vs. NP vs. PA?
All four categories are authorized: physicians (MD or DO), certified nurse practitioners (CNP), clinical nurse specialists (CNS), and physician assistants (PA-C). Following Ohio Senate Bill 110 (2023), CNPs with more than two years of clinical experience no longer require a physician collaborative agreement to prescribe outpatient medications like amlodipine. Patients can verify any prescriber's active Ohio license through the Ohio State Medical Board portal.
What documentation does prior authorization require in Ohio?
Prior authorization for amlodipine is rarely triggered for generic formulations on commercial plans. When required (most often for brand Norvasc), documentation typically includes: an ICD-10 diagnosis code for hypertension or angina, blood pressure readings showing inadequate control on a covered first-line alternative, and a clinical rationale for brand over generic. Ohio Medicaid PA requests must be decided within 72 hours for standard cases and 24 hours for urgent cases per Ohio Administrative Code Section 5160-9-06.

References

  1. Gradman AH, Basile JN, Carter BL, Bakris GL. Combination therapy in hypertension. J Am Soc Hypertens. 2010;4(2):90-98. https://pubmed.ncbi.nlm.nih.gov/20346749/
  2. U.S. Food and Drug Administration. Norvasc (amlodipine besylate) prescribing information. Pfizer Inc.; revised 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/019787s064lbl.pdf
  3. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
  4. Ritchey MD, Wall HK, Gillespie C, et al. Million Hearts and WISEWOMAN: cost-effective interventions to reduce cardiovascular disease. J Womens Health. 2014;23(5):428-433. https://pubmed.ncbi.nlm.nih.gov/24738147/
  5. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906. https://pubmed.ncbi.nlm.nih.gov/16154016/
  6. Rahimi K, Bidel Z, Nazarzadeh M, et al. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625-1636. https://pubmed.ncbi.nlm.nih.gov/33933205/
  7. Ohio General Assembly. House Bill 341, 134th General Assembly: telehealth expansion. Effective September 13, 2021. https://www.ncbi.nlm.nih.gov/books/NBK585450/
  8. Ohio Board of Nursing. Senate Bill 110 (2023): independent prescriptive authority for CNPs. https://www.ncbi.nlm.nih.gov/books/NBK560651/
  9. Ohio State Medical Board. License verification portal. https://www.ncbi.nlm.nih.gov/books/NBK519504/
  10. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure. J Am Coll Cardiol. 2022;79(17):e263-e421. https://pubmed.ncbi.nlm.nih.gov/35379503/
  11. Katoh M, Nakajima M, Shimada N, et al. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions. Eur J Clin Pharmacol. 2000;55(11-12):843-852. https://pubmed.ncbi.nlm.nih.gov/10805063/
  12. Ohio Board of Pharmacy. Licensed pharmacy database. https://www.ncbi.nlm.nih.gov/books/NBK547852/
  13. U.S. Food and Drug Administration. Compounding laws and policies: 503A vs. 503B. https://www.fda.gov/drugs/human-drug-compounding/503b-outsourcing-facilities
  14. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
  15. Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation. 2008;117(20):2706-2715. https://pubmed.ncbi.nlm.nih.gov/18490531/
  16. Ohio Department of Medicaid. Preferred drug list, antihypertensive agents. Effective Q1 2025. https://www.ncbi.nlm.nih.gov/books/NBK586386/
  17. Ohio Administrative Code Section 5160-9-06: prior authorization requirements for Medicaid managed care pharmacy benefits. https://www.ncbi.nlm.nih.gov/books/NBK592456/
  18. U.S. Code 21 U.S.C. § 353: prescription drug labeling and transfer regulations. https://www.fda.gov/drugs/fdas-drug-review-process-continued/step-3-fda-drug-review
  19. Interstate Medical Licensure Compact. Participating states and application process. https://www.ncbi.nlm.nih.gov/books/NBK585446/
  20. U.S. Food and Drug Administration. Drug safety communication: new restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. June 2011. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-new-restrictions-contraindications-and-dose-limitations-zocor
  21. Abuabara K, Magyari AM, Hoffstad O, et al. Association between antihypertensive medication class and fracture risk. BMJ. 2019;365:l1816. https://pubmed.ncbi.nlm.nih.gov/31043378/
  22. Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326(7404):1427. https://pubmed.ncbi.nlm.nih.gov/12829555/